It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

This contract manufacturer in medical devices reported a notable insider sale as it continues to serve global OEM customers.

Integer (ITGR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

ITGR's strong product sales and R&D momentum support growth outlook, but near-term product adoption delays and margin pressure remain key risks.

Shares of Integer (NYSE: ITGR), a company specializing in the development and manufacturing of medical devices, saw a substantial decline of 32% on October 23, 2025. This notable drop was mainly due to the company’s updated financial projections for the ...

Integer Technologies, a leading provider of adaptive artificial intelligence (AI) defense technologies for cyber-physical resilience, today announced a strategic partnership with the

Integer Holdings ITGR witnessed strong momentum in the past year. Shares of the company have gained 34.4% compared with the 4.2% rise of the industryin the same time frame. The S&P 500 Composite has risen 25.6% during the same period. With healthy ...

Business: Integer Holdings Corporation is a medical device contract development and manufacturing company. Its brands include Greatbatch Medical and Lake Region Medical. The company's Cardio & Vascular product line offers a range of components ...